Melanoma, immune surveillance, and immunotherapy.
Open Access
- 1 April 1994
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 93 (4) , 1351-1352
- https://doi.org/10.1172/jci117108
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Selective loss of human leukocyte class I allospecificities and staining of melanoma cells by monoclonal antibodies recognizing monomorphic determinants of class I human leukocyte antigens.1993
- Identification of human cancers deficient in antigen processing.The Journal of Experimental Medicine, 1993
- Human high molecular weight melanoma-associated antigen (HMW-MAA) mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: induction of humoral anti-HMW-MAA immunity and prolongation of survival in patients with stage IV melanoma.Proceedings of the National Academy of Sciences, 1992
- T cell responses to human malignant tumours.1992
- MHC antigens in human melanomas.1991
- Use of Tumor-Infiltrating Lymphocytes and Interleukin-2 in the Immunotherapy of Patients with Metastatic MelanomaNew England Journal of Medicine, 1988
- Vaccines containing purified GM2 ganglioside elicit GM2 antibodies in melanoma patients.Proceedings of the National Academy of Sciences, 1987